Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling J EXP MED
The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78 Blood
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation Cancer Cell
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project Blood
The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia CANCER CELL
A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas Nat Med
Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models P NATL ACAD SCI USA
Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines Cancer Res
Disruption of mitochondrial membrane potential during apoptosis induced by PSC 833 and CsA in multidrug-resistant lymphoid leukemia TOXICOL APPL PHARM
Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype LEUKEMIA RES